Ovid Therapeutics Inc Asset Turnover Ratio (OVID), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Ovid Therapeutics Inc   (NASDAQ: OVID)
 

Ovid Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Ovid Therapeutics Inc 's asset turnover ratio sequentially decreased to 0.01 in the second quarter (Jun 30 2026), but remained above the company's average. For every Dollar on the Balance Sheet, Ovid Therapeutics Inc realized $0.01 in annual sales.

Within sector Ovid Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OVID Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Asset Change 199.6 % 176.32 % 83.29 % -29.42 % -27.34 %
Y / Y Revenue Change -88.31 % - 844.74 % -23.7 % 3611.24 %
Asset Turnover Ratio (TTM) 0.01 - 0.08 0.09 0.08
OVID's Total Ranking # # # # #
Seq. Asset Change 2.81 % 49.49 % 136.4 % -17.54 % -5.18 %
Seq. Revenue Change - - 443.94 % -97.9 % 4724.62 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




OVID Company Profile • Back to OVID Efficiency Comparisons • Compare OVID Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Hyperion Defi inc   0.02 $ 1.401  Millions$ 79.440  Millions
Aspire Biopharma Holdings Inc   0.02 $ 0.103  Millions$ 6.093  Millions
Ataibeckley Inc   0.02 $ 4.473  Millions$ 265.553  Millions
Alumis inc   0.01 $ 7.398  Millions$ 533.040  Millions
Vyne Therapeutics Inc   0.01 $ 0.430  Millions$ 31.089  Millions
Anteris Technologies Global Corp   0.01 $ 2.242  Millions$ 166.751  Millions
Vivosim Labs Inc   0.01 $ 0.112  Millions$ 8.892  Millions
Envoy Medical Inc   0.01 $ 0.207  Millions$ 17.628  Millions
Bellevue Life Sciences Acquisition Corp  0.01 $ 1.809  Millions$ 171.835  Millions
Cardiff Oncology Inc   0.01 $ 0.508  Millions$ 53.041  Millions
Upstream Bio Inc   0.01 $ 3.158  Millions$ 336.048  Millions
Sharps Technology Inc   0.01 $ 2.468  Millions$ 263.597  Millions
Clene Inc   0.01 $ 0.197  Millions$ 21.287  Millions
Scienture Holdings Inc   0.01 $ 0.821  Millions$ 89.351  Millions
Absci Corp  0.01 $ 1.561  Millions$ 231.450  Millions
Aclarion Inc   0.01 $ 0.084  Millions$ 16.388  Millions
Lightwave Logic Inc 0.00 $ 0.250  Millions$ 79.491  Millions
Pavmed Inc 0.00 $ 0.126  Millions$ 40.629  Millions
Prokidney Corp 0.00 $ 0.818  Millions$ 307.246  Millions
IMPACT BIOMEDICAL INC. 0.00 $ 0.035  Millions$ 17.361  Millions
Cardio Diagnostics Holdings Inc 0.00 $ 0.014  Millions$ 8.510  Millions
Roivant Sciences Ltd 0.00 $ 7.532  Millions$ 5,378.680  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.